mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.02 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.02 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.02 |
mRNA |
AA-COCF3 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.02 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.02 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.02 |
mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.02 |